Trials that use: Intention-to-treat analysis
New to this method? Read the tutorial →
10,079 results
- Molecular-Guided Therapy for Childhood Cancer: Complete Statistical AnalysisIndependent statistical analysis of Molecular-Guided Therapy for Childhood Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02162732).
- Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG): Complete Statistical AnalysisIndependent statistical analysis of Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01182350).
- MOLTIndependent statistical analysis of Mechanisms of Light-based Therapies for Dry Eye Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06004895).
- MOMSIndependent statistical analysis of Management of Myelomeningocele Study (MOMS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00060606).
- Mona LisaIndependent statistical analysis of Clinical Evaluation of the GLYDe Dressing for Post-surgical Incision Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00766727).
- MONALEESA-2Complete statistical analysis of MONALEESA-2, the randomized phase 3 trial of ribociclib plus letrozole versus placebo plus letrozole in postmenopausal women with advanced or metastatic breast cancer.
- MONALEESA-2Independent statistical analysis of Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- MONALEESA-7Independent statistical analysis of MONALEESA-7, a randomized phase 3 trial of ribociclib plus endocrine therapy and goserelin versus placebo plus endocrine therapy and goserelin in premenopausal women with hormone receptor-positive, HER2-negative advanced…
- MONARCH 1Independent statistical analysis of A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MONARCH plusIndependent statistical analysis of A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02763566).
- MONETIndependent statistical analysis of the randomized phase 3 MONET trial of darunavir/ritonavir once daily versus darunavir/ritonavir plus two NRTIs, including its non-inferiority design, time-to-event endpoint, risk-difference estimates, confidence intervals, and statistical interpretation.
- Monitoring of Symptoms and Cognitive Function Using Telehealth: Complete Statistical AnalysisIndependent statistical analysis of Monitoring of Symptoms and Cognitive Function Using Telehealth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03184701).
- Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma: Complete Statistical AnalysisIndependent statistical analysis of Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Monocyte Priming When Consuming a Western Diet: Complete Statistical AnalysisIndependent statistical analysis of Monocyte Priming When Consuming a Western Diet: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05348395).
- Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00549328).
- MONOVISC for Hip Joint Pain Relief Due to Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of MONOVISC for Hip Joint Pain Relief Due to Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04204083).
- Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367): Complete Statistical AnalysisIndependent statistical analysis of Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00442559).
- Montelukast in Perennial Allergic Rhinitis – 2001-2002 Study (0476-246): Complete Statistical AnalysisIndependent statistical analysis of Montelukast in Perennial Allergic Rhinitis - 2001-2002 Study (0476-246): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00974571).
- Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin: Complete Statistical AnalysisIndependent statistical analysis of Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MORE-CAREIndependent statistical analysis of MOnitoring REsynchronization deviCes and cARdiac patiEnts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00885677).
- MORNDIABIndependent statistical analysis of Morbidity in Newly Diagnosed type2 Diabetes in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02002091).
- MORPHEOIndependent statistical analysis of A Phase 4, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Persistent Asthma: primary endpoint results, effect estimate…
- Morpheus LungIndependent statistical analysis of A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer): primary endpoint results, effect estimate with confidence interval,…
- Morphological Pattern of the Atrophic Posterior Maxillae: Complete Statistical AnalysisIndependent statistical analysis of Morphological Pattern of the Atrophic Posterior Maxillae: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02833337).
- MOST EMPOWERIndependent statistical analysis of MOST EMPOWER: Optimizing An Emotion Regulation Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04317417).
- MOTIONIndependent statistical analysis of A Phase 2 Study to Evaluate the Impact of MTP-131 (Bendavia™) on Skeletal Muscle Function in Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness: Complete Statistical AnalysisIndependent statistical analysis of Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- MOTIVATE-HFIndependent statistical analysis of MOTIVATional intErviewing to Improve Self-care in Heart Failure Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02894502).
- Motor Imagery Intervention for Improving Gait and Cognition in the Elderly: Complete Statistical AnalysisIndependent statistical analysis of Motor Imagery Intervention for Improving Gait and Cognition in the Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Motorized Continuous Cold Therapy Versus Standard Post-op Icing Protocol for Two Foot and Ankle Procedures: Complete Statistical AnalysisIndependent statistical analysis of Motorized Continuous Cold Therapy Versus Standard Post-op Icing Protocol for Two Foot and Ankle Procedures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MoTrPACIndependent statistical analysis of Molecular Transducers of Physical Activity Consortium (MoTrPAC) - Pediatric Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04151199).
- MOVEIndependent statistical analysis of Randomized, Double-blind, Placebo-controlled, Multicenter, Cross-over Study to Assess the Effects of a 3 Week Therapy Each With QVA149 Versus Placebo on Pulmonary Function and Average Physical Activity Levels…
- Move For Your Health for Older Cancer Survivors: Complete Statistical AnalysisIndependent statistical analysis of Move For Your Health for Older Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05582889).
- MOVe-AHEADIndependent statistical analysis of the phase 3 MOVe-AHEAD trial of molnupiravir for prevention of Coronavirus Disease (COVID-19) in adults, including endpoint definitions, score-based confidence intervals, reported results, safety, and statistical interpretation.
- MOVE!+UP: Testing a Tailored Weight Management Program for Veterans With PTSD: Complete Statistical AnalysisIndependent statistical analysis of MOVE!+UP: Testing a Tailored Weight Management Program for Veterans With PTSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MOVESIndependent statistical analysis of MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03820024).
- MOXIIndependent statistical analysis of Myogenic and Osteogenic Responses to eXercise and Ibuprofen: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00462722).
- MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01180634).
- MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial): Complete Statistical AnalysisIndependent statistical analysis of MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05780463).
- MR-Guided Laser Interstitial Thermal Therapy in Treating Patients With Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of MR-Guided Laser Interstitial Thermal Therapy in Treating Patients With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MRCC RCCIndependent statistical analysis of Safety And Efficacy Study Of Sunitinib Malate As First-Line Systemic Therapy In Chinese Patients With Metastatic Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size…
- MRCP: A Reliable, Non Invasive Method for Staging Chronic Pancreatitis in Pediatrics: Complete Statistical AnalysisIndependent statistical analysis of MRCP: A Reliable, Non Invasive Method for Staging Chronic Pancreatitis in Pediatrics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MRI Guided SBRT for Localized Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of MRI Guided SBRT for Localized Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03778112).
- MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) (COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) (COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval,…
- MSC2015103B in Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of MSC2015103B in Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01453387).
- MSG-01Independent statistical analysis of Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- MTBVACIndependent statistical analysis of Dose-Escalation Study to Evaluate the Safety and Immunogenicity of MTBVAC Vaccine in Comparison With BCG Vaccine.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Mu-Opioid Receptor Genetic Polymorphism and Intrathecal Analgesia: Complete Statistical AnalysisIndependent statistical analysis of Mu-Opioid Receptor Genetic Polymorphism and Intrathecal Analgesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00418015).
- MUCINIndependent statistical analysis of Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…